Bicocca Open Archive

Logo unimib boa
DI FRANCESCO, JACOPO COSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.955
AS - Asia 4.869
EU - Europa 4.178
SA - Sud America 788
AF - Africa 139
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 9
Totale 18.949
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.547
SG - Singapore 1.731
CN - Cina 1.106
IT - Italia 917
DE - Germania 779
VN - Vietnam 599
BR - Brasile 596
RU - Federazione Russa 559
HK - Hong Kong 555
SE - Svezia 405
CA - Canada 321
IE - Irlanda 295
GB - Regno Unito 274
FI - Finlandia 194
FR - Francia 183
UA - Ucraina 181
IN - India 179
BD - Bangladesh 105
TR - Turchia 80
AT - Austria 78
IQ - Iraq 75
AR - Argentina 69
ID - Indonesia 57
JP - Giappone 56
ES - Italia 55
ZA - Sudafrica 53
MX - Messico 51
KR - Corea 48
NL - Olanda 46
PL - Polonia 45
PK - Pakistan 41
DK - Danimarca 37
BE - Belgio 35
PH - Filippine 30
EC - Ecuador 29
UZ - Uzbekistan 28
SA - Arabia Saudita 25
CL - Cile 23
AE - Emirati Arabi Uniti 22
CO - Colombia 21
VE - Venezuela 21
CH - Svizzera 20
MA - Marocco 20
MY - Malesia 18
IR - Iran 12
EG - Egitto 10
LB - Libano 10
PY - Paraguay 10
AZ - Azerbaigian 9
HU - Ungheria 9
KE - Kenya 9
PS - Palestinian Territory 9
LT - Lituania 8
OM - Oman 8
PE - Perù 8
PT - Portogallo 8
RO - Romania 8
TN - Tunisia 8
DO - Repubblica Dominicana 7
ET - Etiopia 7
EU - Europa 7
GE - Georgia 7
JO - Giordania 7
KZ - Kazakistan 7
NP - Nepal 7
PA - Panama 7
AL - Albania 6
AU - Australia 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
JM - Giamaica 6
NG - Nigeria 6
TH - Thailandia 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
BO - Bolivia 5
CR - Costa Rica 5
GR - Grecia 5
IL - Israele 5
KW - Kuwait 5
MD - Moldavia 4
NI - Nicaragua 4
UY - Uruguay 4
AO - Angola 3
BG - Bulgaria 3
BY - Bielorussia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
MN - Mongolia 3
QA - Qatar 3
UG - Uganda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
EE - Estonia 2
MU - Mauritius 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 18.922
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.681
Singapore 1.093
Ashburn 751
Hong Kong 545
San Jose 532
Chandler 418
Fairfield 414
Frankfurt am Main 412
Woodbridge 405
Wilmington 387
Dublin 286
Houston 285
Milan 273
New York 246
Santa Clara 217
Toronto 203
Beijing 186
Los Angeles 182
Jacksonville 180
Munich 179
Dearborn 173
Seattle 168
Ho Chi Minh City 167
Cambridge 140
Council Bluffs 135
Hanoi 129
Dallas 123
Helsinki 120
Princeton 118
Chicago 117
The Dalles 101
Nanjing 88
São Paulo 73
Shanghai 70
Buffalo 68
Hefei 68
Lauterbourg 64
Vienna 61
Moscow 58
Lawrence 49
Orem 49
Seoul 42
Rome 41
Altamura 39
Dong Ket 37
Jakarta 37
Tokyo 37
Baghdad 34
Da Nang 31
Guangzhou 31
Lachine 31
Denver 30
Johannesburg 30
London 30
Montreal 29
Brooklyn 28
Nuremberg 28
Tashkent 28
Brussels 27
Boardman 26
Warsaw 26
Sesto San Giovanni 25
Chennai 24
Jinan 23
Ottawa 23
Rio de Janeiro 23
Andover 22
Boston 22
Monza 22
Pune 22
San Diego 22
Grafing 21
Nanchang 20
Atlanta 19
Fremont 19
Ankara 18
Changsha 18
Haiphong 18
Santiago 18
Stockholm 18
Bologna 17
Manchester 17
Phoenix 17
Shenyang 17
Zhengzhou 17
Poplar 16
Tianjin 16
Amsterdam 15
Hangzhou 15
Turku 15
Istanbul 14
Kocaeli 14
Mexico City 14
Columbus 13
Dhaka 13
Salt Lake City 13
San Francisco 13
Falls Church 12
Lissone 12
New Delhi 12
Totale 12.345
Salva come PNG Salva come JPEG
Nome #
Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation 508
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 506
Cardiac and neuronal HCN channelopathies 480
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy 458
Effect of the ketogenic diet in excitable tissues 429
Clinical, biological and neuroradiological evolution of Cerebral Amyloid Angiopathy-related inflammation: the iCAβ International Network longitudinal study. 410
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer's disease and cerebral amyloid angiopathy 403
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 399
Implementation of continuous qEEG in two neurointensive care units by intensivists: a feasibility study 372
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 365
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 363
Progressive epileptic encephalopathy associated with a novel HCN2 mutation 362
Generation and validation of algorithms to identify subjects with dementia using administrative data 352
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 350
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 338
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 330
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 320
Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients? 319
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 315
Novel neurofibromatosis type 2 mutation presenting with status epilepticus 299
Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Aβ Autoantibodies 299
Cerebellar hematoma in a carrier of the A3243G MELAS mutation 292
Brain targets: can you believe your own eyes? 292
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-A beta auto-antibodies 288
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 285
Cerebral Amyloid Angiopathy-Related Inflammation 279
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 274
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet 266
Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation 262
Long-term risk of chronic epilepsy in adults after post-anoxic coma and refractory status epilepticus: A retrospective cohort study 262
HCN1 novel mutations in familiar generalized epilepsy 261
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease 257
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 254
A case of Leber hereditary optic neuropathy plus dystonia caused by G14459A mitochondrial mutation 254
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 249
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 249
Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review 246
HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond 243
Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 242
Neurological soft signs are increased in migraine without aura: relationship with the affective status 239
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 235
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 234
Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project 234
MELAS mitochondrial DNA mutation A3243G reduces glutamate transport in cybrids cell lines 230
Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes 230
Cerebral amyloid angiopathy-related inflammation: an emerging disease 228
Epilepsy in Cerebral Amyloid Angiopathy: an observational retrospective study of a large population 227
Epilptic seizures and psychogenic non-epileptic seizures 227
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 225
Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-Aβ Autoantibodies 223
Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network 218
Autoimmune encephalopathy in Graves' disease: Remission after total thyroidectomy 214
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 212
Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study 208
A loss-of-function HCN4 mutation associated with familial benign myoclonic epilepsy in infancy causes increased neuronal excitability 199
Anti-Aß autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 197
Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW) 195
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-Aβ auto-antibodie 194
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 185
Recessive loss-of-function mutation in the pacemaker HCN2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsy 185
Complicanze neurologiche di malattie internistiche 184
Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management 184
The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study 181
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study 178
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 171
LATE-ONSET EPILEPSY WITH UNKNOWN ETIOLOGY: A PILOT STUDY ON NEUROPSYCHOLOGICAL PROFILE, CEREBROSPINAL FLUID BIOMARKERS, AND QUANTITATIVE EEG CHARACTERISTICS 169
Anti-AB autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's disease Biomarkers Collaborative Network 167
CSF and Plasma Biomarkers in Patients With Iatrogenic Cerebral Amyloid Angiopathy 117
Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series 86
Management of epilepsy in older adults: A critical review by the ILAE Task Force on Epilepsy in the elderly 68
The hidden link between late-onset seizures and cerebral amyloid angiopathy: A case–control study 48
The epidemiology of epilepsy in older adults: A narrative review by the ILAE Task Force on Epilepsy in the Elderly 38
Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP2-Dependent K+ Channel Gating 35
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 32
Progressive myoclonus epilepsies due to SEMA6B mutations. New variants and appraisal of published phenotypes 31
Determinants of cerebral amyloid angiopathy progression: a multicenter retrospective study 30
Next-generation sequencing in pediatric-onset epilepsies: Analysis with target panels and personalized therapeutic approach 29
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy 28
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy 28
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 28
Severe epilepsy phenotypes in adults with succinic semialdehyde dehydrogenase deficiency: Novel clinical and therapeutic insights from an Italian multicenter retrospective cohort study 28
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study 28
Dysfunctional HCN ion channels in neurological diseases 28
Etiological diagnosis of late-onset epilepsy: A key priority for Italian epileptologists – Insights from a LICE survey 27
Clinical-radiological presentation and natural history of iatrogenic cerebral amyloid angiopathy 27
Iatrogenic cerebral amyloid angiopathy: A multinational case series and individual patient data analysis of the literature 26
Cerebrospinal Fluid β-Amyloid and τ Levels in Patients With Iatrogenic Cerebral Amyloid Angiopathy, Sporadic Cerebral Amyloid Angiopathy, Alzheimer Disease, and Controls 26
Compound Heterozygous PNKP Variants Causing Developmental and Epileptic Encephalopathy with Severe Microcephaly: Natural History of Two New Cases and Literature Review 23
Pharmacological approaches in drug-resistant pediatric epilepsies caused by pathogenic variants in potassium channel genes 22
Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures 22
Early Parkinsonism in a Senegalese girl with Lafora disease 22
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study 22
Iatrogenic cerebral amyloid angiopathy after red blood cell transfusion? 22
Long-term analysis of the effects of COVID-19 in people with epilepsy: Results from a multicenter on-line survey across the pandemic waves 21
Effectiveness of perampanel as the only add-on: Retrospective, multicenter, observational real-life study on epilepsy patients 21
Impaired occipital cerebrovascular reactivity as a biomarker for vascular β-amyloid 20
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study 20
Relevance of clinical context in the diagnostic-therapeutic approach to status epilepticus 19
Alternating Hemiplegia and Epilepsia Partialis Continua: A new phenotype for a novel compound TBC1D24 mutation 19
SCN8A splicing mutation causing skipping of the exon 15 associated with intellectual disability and cortical myoclonus 18
Totale 19.564
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.661
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021293 0 0 0 0 0 0 0 0 0 0 128 165
2021/20221.105 131 125 127 95 92 102 40 47 52 50 83 161
2022/20231.767 173 493 166 193 130 246 35 86 171 12 27 35
2023/20241.090 28 66 49 73 156 262 168 59 78 13 19 119
2024/20252.872 137 291 164 101 231 187 270 156 312 423 225 375
2025/20267.619 798 344 525 898 921 349 1.024 678 703 926 453 0
Totale 19.718